Company Filing History:
1 out of 237 
1 out of 5,076 
1 out of 1,743 
Years Active: 2022
Title: The Innovations of Nicolas Pietrancosta
Introduction
Nicolas Pietrancosta is an accomplished inventor based in Montigny le Bretonneux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mood-related disorders. His innovative work focuses on the development of selective organic cation transporters inhibitors.
Latest Patents
Nicolas Pietrancosta holds a patent for "Selective organic cation transporters inhibitors for the treatment of depressive disorders." This patent discloses organic cation transporters (OCTs) inhibitors of Formula (A), along with their pharmaceutically acceptable tautomers, salts, or solvates. The patent also includes pharmaceutical compositions that utilize these OCTs inhibitors for treating and preventing mood-related disorders, such as depressive disorders.
Career Highlights
Throughout his career, Nicolas has worked with prestigious institutions, including Sorbonne Université and the Centre National de la Recherche Scientifique. His research has focused on developing innovative solutions to address mental health challenges.
Collaborations
Nicolas has collaborated with notable colleagues, including Sophie Gautron and Francine Acher. Their combined expertise has contributed to advancements in the field of pharmacology.
Conclusion
Nicolas Pietrancosta's work exemplifies the impact of innovation in the treatment of depressive disorders. His contributions to the field through his patent and collaborations highlight the importance of research in improving mental health outcomes.